Lv1
20 积分 2025-07-14 加入
The Intravenous to Oral Switch of Taxanes: Strategies and Current Clinical Developments
1天前
待确认
The Intravenous to Oral Switch of Taxanes: Strategies and Current Clinical Developments
1天前
已关闭
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
5个月前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
5个月前
已完结
Discovery of 12 (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic Disorders
10个月前
已完结
The non-small-cell lung cancer drug market
11个月前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
11个月前
已完结
GLP-1-based therapies for diabetes, obesity and beyond
1年前
已完结
Dual-payload ADCs move into first oncology clinical trials
1年前
已完结
皖公网安备34019202002308
